期刊文献+

曲古抑菌素A对小鼠混合淋巴细胞培养中淋巴细胞增殖和IL-2表达的影响 被引量:4

Effect of trichostatin A on proliferation and interleukin-2 expression of mouse T cells in mixed lymphocyte culture
下载PDF
导出
摘要 目的研究曲古抑菌素A(TSA)对小鼠体外混合淋巴细胞培养中淋巴细胞增殖及IL-2表达的影响,探讨TSA对T细胞免疫功能的影响。方法采用0.16、0.8、4、20、100、500nmol/L倍比浓度TSA作用于BALB/c及C57BL小鼠混合淋巴细胞培养体系,根据不同的OD值测定12、24、48h各浓度TSA对T淋巴细胞增殖的抑制率;相同浓度梯度TSA再作用于经丝裂霉素处理过的BALB/c淋巴细胞与C57BL淋巴细胞单向混合淋巴细胞培养体系,以环磷酰胺作对照,应用流式细胞技术观察其对IL-2表达的影响。结果TSA可以抑制小鼠混合淋巴细胞培养中T淋巴细胞的增殖,这种抑制能力表现出明显的量效及时效依赖性;TSA也显著抑制经刺激激活的小鼠T淋巴细胞的IL-2的表达,并且随着TSA浓度的升高,IL-2表达逐步下降,但与CTX比较有显著性差异(P<0.01)。结论TSA能抑制混合淋巴细胞培养中淋巴细胞的增殖,减少激活T淋巴细胞IL-2的表达,降低T细胞的免疫活性,能够减弱对外来抗原刺激的免疫应答。 Objective To investigate the effect of trichostatin A (TSA) on proliferation and interlenkin-2 (IL-2) expression of mouse T cells in mixed lymphocyte culture (MLC), and explore its effect on T cell-mediated immune response. Methods BALB/c and C57BL mouse MLC was treated with different concentrations of TSA for different durations, and the lymphocyte inhibition ratio was measured by MTT assay. With CTX as the control, one-way MLC system of BALB/c and C57BL mouse was treated with the same concentrations of TSA, and IL-2 expression in the T cells was observed by flow cytometry. Results TSA inhibited the proliferation of T cells in the MLC in a time- and dose-dependent fashion. It also reduced the IL-2 expression in one-way MLC dose-dependently, showing it significantly differed from the effect of CTX (P〈0.01). Conclusion Histone deacctylase inhibitor TSA can inhibit the proliferation and reduce IL-2 expression of the T cells in MLC of mice, and therefore inhibit the T cell-mediated immune rvsponse.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2008年第3期467-469,共3页 Journal of Southern Medical University
关键词 曲古抑菌素A 混合淋巴细胞培养 去乙酰化酶抑制剂 白细胞介素-2 trichostatin A mixed lymphocyte culture histone deacetylase immune suppression interlenkin-2
  • 相关文献

参考文献8

  • 1Foumel M, Trachy-Bourget MC, Yah PT, et al. Sulfonamide anilides, a novel class of histone deacetylase inhibitors, are antiproliferative against human tumors [J]. Cancer Res, 2002, 62: 4325-30.
  • 2Dangond F, Gullans SR. Differential expression of human histone deacetylase mRNAs in response to immune cell apoptosis induction by trichostatin A and butyrate [ J ]. Biochem Biophys Res Commun, 1998, 247(3):833-7.
  • 3Moreira JM, Scheipers P, Sorensen P. The histone deacetylase inhibitor Trichostatin A modulates CD4+ T cell responses [J]. BMC Cancer, 2003, 3:30.
  • 4Koyama Y, Adachi M, Sekiya M, et al. Histone deacetylase inhibitors suppress IL-2-mediated gene expression prior to induction of apoptosis [ J ]. Blood, 2000, 96:1490-5.
  • 5Lu J, Sun H, Wang X, et al. Interleukin-12 p40 promoter activity is regulated by the reversible acetylation mediated by HDACI and p300 [ J ]. Cytokine, 2005, 31:46-51.
  • 6Leng C, Gries M, Ziegler J,et al. Reduction of graft-versus-host disease by histone deacetylase inhibitor suberonylanilide hydroxamic acid is associated with modulation of inflammatory cytokine milieu and involves inhibition of STAT1 [J]. Exp Hematol, 2006, 34:776-87.
  • 7Tian L, Qu X, Wang ME, et al. Selective inhibition of IL-2 mRNA blocks aUografl rejection by limiting T cell clonal expansion [J]. Transplant Proc, 2001, 33:330.
  • 8Bohmig GA, Krieger PM, Saemann MD, et al. Stable prodrugs of n-butyric acid: suppression of T cell alloresponses in vitro and prolongation of heart allografl survival in a fully allogeneic rat strain combination[ J]. Transplant Immunol, 1999, 7:221-7.

同被引文献26

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部